Last reviewed · How we verify

NCT05691439: MoDA

Mechanisms of Depression and Anhedonia in Adolescents: Linking Sleep to Reward- and Stress-Related Brain Function

Recruiting now NA Last updated 17 November 2025
What this trial tests

NA trial testing Sleep extension and advance in Depression in Adolescence in 150 participants. Currently enrolling.

Timeline
27 March 2023
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorUniversity of Oregon
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment150
Start date27 March 2023
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Oregon

Who can join

Adults 14 to 18, any sex, with Depression in Adolescence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research will use biobehavioral approaches to generate understanding about the linkages between sleep duration and timing, stressful life events, and depressive symptoms in adolescents, with a long-term aim of developing effective preventative interventions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sleep extension and advance

Trials testing the same drug.

Other recruiting trials for Depression in Adolescence

Currently open trials in the same condition.

Other University of Oregon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05691439.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing